These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37679689)

  • 21. MicroRNA-511-3p regulates Aβ
    Wang T; Zhao W; Liu Y; Yang D; He G; Wang Z
    Exp Gerontol; 2023 Jul; 178():112195. PubMed ID: 37121335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.
    Liu CH; Bu XL; Wang J; Zhang T; Xiang Y; Shen LL; Wang QH; Deng B; Wang X; Zhu C; Yao XQ; Zhang M; Zhou HD; Wang YJ
    J Alzheimers Dis; 2016 Apr; 52(3):1081-8. PubMed ID: 27079706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer's disease.
    Lu G; Liu W; Huang X; Zhao Y
    Arq Neuropsiquiatr; 2020 Feb; 78(2):76-80. PubMed ID: 32022122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease.
    Alvarez XA; Franco A; Fernández-Novoa L; Cacabelos R
    Mol Chem Neuropathol; 1996; 29(2-3):237-52. PubMed ID: 8971699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leptin, hsCRP, TNF-α and IL-6 levels from normal aging to dementia: Relationship with cognitive and functional status.
    Magalhães CA; Ferreira CN; Loures CMG; Fraga VG; Chaves AC; Oliveira ACR; de Souza LC; Resende EPF; Carmona KC; Guimarães HC; Cintra MTG; Lanna IN; Zauli DAG; Bicalho MA; Carvalho MG; Sousa LP; Caramelli P; Gomes KB
    J Clin Neurosci; 2018 Oct; 56():150-155. PubMed ID: 30150062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.
    Hesse R; Wahler A; Gummert P; Kirschmer S; Otto M; Tumani H; Lewerenz J; Schnack C; von Arnim CA
    BMC Neurol; 2016 Sep; 16(1):185. PubMed ID: 27671345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease.
    Rui W; Xiao H; Fan Y; Ma Z; Xiao M; Li S; Shi J
    J Neuroinflammation; 2021 Dec; 18(1):280. PubMed ID: 34856990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
    Lai KSP; Liu CS; Rau A; Lanctôt KL; Köhler CA; Pakosh M; Carvalho AF; Herrmann N
    J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):876-882. PubMed ID: 28794151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of peripheral inflammatory markers between normal control and Alzheimer's disease.
    Kim SM; Song J; Kim S; Han C; Park MH; Koh Y; Jo SA; Kim YY
    BMC Neurol; 2011 May; 11():51. PubMed ID: 21569380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of vitamin D on cognitive function and white matter hyperintensity in patients with mild Alzheimer's disease.
    Shih EJ; Lee WJ; Hsu JL; Wang SJ; Fuh JL
    Geriatr Gerontol Int; 2020 Jan; 20(1):52-58. PubMed ID: 31773862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease.
    Bawa KK; Krance SH; Herrmann N; Cogo-Moreira H; Ouk M; Yu D; Wu CY; Black SE; Lanctôt KL; Swardfager W;
    J Neuroinflammation; 2020 Mar; 17(1):84. PubMed ID: 32171317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects.
    Kumar A; Verma A; Chaurasia RN
    Neurosci Lett; 2023 Jan; 795():137044. PubMed ID: 36592816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired lipoprotein receptor-mediated peripheral binding of plasma amyloid-β is an early biomarker for mild cognitive impairment preceding Alzheimer's disease.
    Sagare AP; Deane R; Zetterberg H; Wallin A; Blennow K; Zlokovic BV
    J Alzheimers Dis; 2011; 24(1):25-34. PubMed ID: 21157031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral inflammation in mild cognitive impairment with possible and probable Lewy body disease and Alzheimer's disease.
    King E; O'Brien JT; Donaghy P; Morris C; Barnett N; Olsen K; Martin-Ruiz C; Taylor JP; Thomas AJ
    Int Psychogeriatr; 2019 Apr; 31(4):551-560. PubMed ID: 30854988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.